Scott G. Ginn - 16 Feb 2025 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
EVP, CFO & COO
Signature
/s/ Jennifer Guckert Griffin, pursuant to a power of attorney
Issuer symbol
AMED
Transactions as of
16 Feb 2025
Net transactions value
-$166,217
Form type
4
Filing time
19 Feb 2025, 21:20:48 UTC
Previous filing
17 Jan 2025
Next filing
24 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Award $0 +17,495 +22% $0.000000 98,281 16 Feb 2025 Direct F1, F2
transaction AMED Common Stock Tax liability $166,217 -1,795 -1.8% $92.60 96,486 16 Feb 2025 Direct F2
holding AMED Common Stock 2,714 16 Feb 2025 Through 401(k) Plan F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer awarded the Reporting Person 17,495 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest 25% on each of February 16, 2026 and February 16, 2027 and 50% on February 16, 2028, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F2 The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.
F3 The information in this report is based on a plan statement dated as of December 31, 2024.